Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
Part of paid clinical trials in Overland Park, Kansas.
- Sponsor
- Kansas City Heart Rhythm Research Foundation
- Study ID
- NCT05464511
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Left atrial appendage occlusion with the dual mechanism closure Amulet device using a novel steerable sheath. — OTHERLeft atrial appendage occlusion with the dual mechanism closure Amulet device using a novel steerable sheath.
Study Details
The novel Amplatzer steerable delivery sheath (Abbott Vascular) is found to be safe and effective in performing LAAO procedure. However, the procedural outcomes have not been compared with the traditional non-steerable fixed curve sheath. In this study investigators aim to compare the outcome of patients undergoing left atrial appendage occlusion with the dual mechanism closure Amulet device using non-steerable fixed curve sheath versus a novel steerable sheath.
Key Dates
- Start date
- Jan 31, 2026
- Status verified
- Oct 2024
- Primary completion
- Oct 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- No Intervention: Patients with Amulet device using non-steerable fixed curve sheathPatients undergoing left atrial appendage occlusion with the dual mechanism closure Amulet device using non-steerable fixed curve sheath.
- Active Comparator: Patients with Amulet device using a novel steerable sheathPatients undergoing left atrial appendage occlusion with the dual mechanism closure Amulet device using a novel steerable sheath.
Primary Outcome Measure
Number of participants with Acute Closure of Left Atrial Appendage [ Time Frame: 1 day ]
Central Contacts
- Donita Atkins816-651-1969
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kansas City Heart Rhythm Institute | Overland Park | Kansas | 66211 | - |
| Menorah Medical Center | Overland Park | Kansas | 66209 | - |
| Overland Park Regional Medical Center | Overland Park | Kansas | 66215 | - |
| Centerpoint Medical Center | Independence | Missouri | 64057 | - |
| Centerpoint Medical Center Clinic | Independence | Missouri | 64057 | - |
| Research Medical Center | Kansas City | Missouri | 64032 | - |
| Research Medical Center Clinic | Kansas City | Missouri | 64032 | - |
Find similar trials in Overland Park, KS
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- User-friendliness of a Portable Driving SimulatorRecruiting · University of Kansas Medical Center · Kansas City, Kansas
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Stroke Thrombectomy and Aneurysm RegistryRecruiting · Medical University of South Carolina · Birmingham, Alabama